Advertisement

Javid J. Moslehi, MD, on Cardiovascular and Thrombotic Considerations of Kinase Inhibitors: The Case of BTK Inhibitors

First International Summit on Interventional Pharmacoeconomics

Advertisement

Related Videos

Opening Session Panel Discussion

Victoria T. Brown, PharmD, BCOP, on Payer Intervention: The Example of Abiraterone

Leonard B. Saltz, MD, on the Future of Interventional Pharmacoeconomics

Clifford A. Hudis, MD: Are Cancer Drug Prices in the U.S. the Problem or the Symptom?

David A. Hyman, MD, JD, on Inclusive Shared Savings

Advertisement

Advertisement

Oct

14

Today In Oncology

Remote Exercise Program Reduces Cancer-Related Fatigue, Improves Quality of Life for Patients Undergoing Immunotherapy

ASCO Remembers Rachna Shroff Expert in Gastrointestinal Cancers

Implementing Massage and Acupuncture to Achieve Better Pain Management in Oncology Care: An Overview of the IMAGINE Project

Daraxonrasib Shows Antitumor Activity in Previously Treated RAS-Mutant NSCLC

Two Phase III Trials Explore B7-H3–Directed ADCs in Relapsed SCLC

Advertisement

© 2026 HSP News Service, L.L.C.